A Case Report and Review of an Atypical Presentation in the Oldest Documented Patient With Susac Syndrome [0.03%]
Susac综合征最年长患者的不典型表现的病例报告和综述
Dana H Chung,Jonathan Amaro-Barron,Jaqueline Stoutin et al.
Dana H Chung et al.
Baseline Features of Optic Neuritis in South Korea: A Retrospective Multicenter Study [0.03%]
韩国视神经炎的基线特征：一项回顾性多中心研究
Yeonji Jang,Yungju Yoo,Haeng-Jin Lee et al.
Yeonji Jang et al.
Background: To investigate the clinical features and serologic test results of optic neuritis through a multi-institutional study in Korea. Methods: ...
Jugular Vein Occlusion-Induced Intracranial Hypertension Mimicking Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator-Associated Intracranial Hypertension: A Diagnostic Pitfall [0.03%]
模仿囊性纤维化跨膜传导调节剂(CFTR)调节剂相关的颅内高压的颈静脉闭塞引起的颅内高压：一个诊断陷阱
Anne Crouzet,Sokaina Ouhnia,Clémence Hoche et al.
Anne Crouzet et al.
Cobalt Toxic Optic Neuropathy in a MT-ND4 m.11778G>A Carrier [0.03%]
含线粒体DNA突变(mt-ND4 m.11778G>A)患者发生的钴毒视神经病变病例报告
Haoran C Li,Jonathan A Micieli
Haoran C Li
Optic Atrophy in Wolfram Syndrome Type 1: A Retrospective Analysis of Visual Outcomes and Biomarker Correlates [0.03%]
Wolframin综合征1型视神经萎缩的回顾性分析：视觉转归及生物标志物相关因素
Bradley J McNeely,Abby F Tang,Fumihiko Urano et al.
Bradley J McNeely et al.
Background: Wolfram syndrome type 1 (WS1) is a rare autosomal recessive disorder classically associated with diabetes mellitus (DM) and optic atrophy (OA). We aimed to characterize OA in WS1 and evaluate optical coherence...
Venous Sinus Stenting With Concomitant Intracranial Pressure Monitoring in a Case of Fulminant Idiopathic Intracranial Hypertension [0.03%]
颅内压监护下行静脉窦支架植入术治疗急性视神经病变型特发性颅内高压症一例
Roy Raheb Khelo,Martina L Mustroph,Michael Dattilo et al.
Roy Raheb Khelo et al.
Homonymous Hemianopia Unveiled: A Treatable Manifestation of Cerebral Convexity Arachnoid Cysts [0.03%]
同侧偏盲的病因：脑凸面蛛网膜囊肿的一种可治疗性疾病
Daniel García-Pérez
Daniel García-Pérez
FOXC1-Related Morning Glory-Like Papillopathy and Cerebral Vasculopathy [0.03%]
FOXC1相关的类似晨星视盘病变和脑血管病
Annie Y Yao,Jose Efren Gonzalez Monroy,Camilo Jaimes et al.
Annie Y Yao et al.
Pro-Con: Antiobesity Drugs Such as Glucagon-Like Peptide-1 Receptor Agonists Should Be a First-Line Treatment in Idiopathic Intracranial Hypertension [0.03%]
利弊分析： glucagon-like peptide-1受体激动剂等抗肥胖药物应作为特发性颅内高压的一线治疗手段
Maria G Lange,Aroucha Vickers,Lisa J Hill et al.
Maria G Lange et al.
Mark J Phillips,Ryan A Gise
Mark J Phillips